PUBLIC CONTRACT · 2023
FORNECIMENTO DE FATOR VIII RECOMBINANTE DE COAGULAÇÃO HUMANA (Octocog Alfa Pó Sol Inj IV 3a Geração)
- Contract value
- €212,437.50
- Signed on
- 11 April 2023
- Procedure
- Open procedure (Concurso público)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9956903PUBLISHED SUBJECT
FORNECIMENTO DE FATOR VIII RECOMBINANTE DE COAGULAÇÃO HUMANA (Octocog Alfa Pó Sol Inj IV 3a Geração)
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Aveiro, Aveiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Takeda Farmacêuticos Portugal, Lda · Tax ID 502801204
- Bidder
- CSL BEHRING · Tax ID 503047201
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €212,437.50
- Procedure base price
- €212,444.37
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 May 2023
- Award date
- 30 March 2023
- Signing date
- 11 April 2023
- Performance period
- 1,096 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Open procedure (Concurso público)
- Award criterion
- Multifator
- CPV code
- 33621200-1 - Anti-hemorrágicos
- Legal basis
- Artigo 20.º, n.º 1, alínea b) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- 1591/2023
- Procedure identifier
- 6308947
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.